April 1, 2026: More Lawsuits Join Vision Loss MDL for GLP-1 Drugs, Like Ozempic As of April 1, 2026, there are 73 pending lawsuits in the centralized litigation for people alleging NAION from GLP-1 drugs, including Ozempic
After that, your doctor will assess your progress and tolerance before increasing the dose
The albumin affinity that governs its pharmacokinetics also affects laboratory work: in any medium containing serum or bovine serum albumin, a substantial fraction of the peptide is protein-bound, so the free concentration at the receptor is lower than the nominal concentration by an amount that depends on the albumin content of the medium
They are not intended to prevent, treat, or cure any illness or disease and are not intended for human consumption
Is it bad to lose weight too quickly